Certolizumab Pegol (Subcutaneous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Certolizumab Pegol (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Cimzia

Description

Certolizumab pegol is a monoclonal antibody. It is used to decrease signs and symptoms of moderately to severely active Crohn's disease in adult patients who have not been helped by other medicines. It is also used to treat the symptoms of moderately to severely active rheumatoid arthritis.

This medicine is available only with your doctor's prescription.

Before Using
DR602647 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger